| MeSH term | MeSH ID | Detail |
|---|---|---|
| Adenocarcinoma | D000230 | 166 associated lipids |
| Colonic Neoplasms | D003110 | 161 associated lipids |
| Cell Transformation, Neoplastic | D002471 | 126 associated lipids |
| Thrombosis | D013927 | 49 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
| Colorectal Neoplasms | D015179 | 10 associated lipids |
| Hypertension | D006973 | 115 associated lipids |
| Familial Mediterranean Fever | D010505 | 12 associated lipids |
| Zellweger Syndrome | D015211 | 39 associated lipids |
| Adenomatous Polyposis Coli | D011125 | 16 associated lipids |
29623-28-7
29623-28-7 is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 1002 references associated with 29623-28-7 in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 29623-28-7
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 29623-28-7
PubChem Associated disorders and diseases
PubChem Biomolecular Interactions and Pathways
NCBI Entrez Crosslinks
All references with 29623-28-7
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Li D et al. | Purified anthocyanin supplementation reduces dyslipidemia, enhances antioxidant capacity, and prevents insulin resistance in diabetic patients. | 2015 | J. Nutr. | pmid:25833778 |
| Jameson JB et al. | A high-throughput mass spectrometric assay for discovery of human lipoxygenase inhibitors and allosteric effectors. | 2015 | Anal. Biochem. | pmid:25712042 |
| pmid:25586578 | ||||
| Chang J et al. | 12/15 Lipoxygenase regulation of colorectal tumorigenesis is determined by the relative tumor levels of its metabolite 12-HETE and 13-HODE in animal models. | 2015 | Oncotarget | pmid:25576922 |
| pmid:25381799 | ||||
| pmid:25330944 | ||||
| pmid:25192306 | ||||
| Daret D et al. | Synthesis of hydroxy fatty acids from linoleic acid by human blood platelets. | 1989 | Prostaglandins | pmid:2505334 |
| Cabral M et al. | Differential cell growth/apoptosis behavior of 13-hydroxyoctadecadienoic acid enantiomers in a colorectal cancer cell line. | 2014 | Am. J. Physiol. Gastrointest. Liver Physiol. | pmid:25035111 |
| Grossi IM et al. | Bidirectional control of membrane expression and/or activation of the tumor cell IRGpIIb/IIIa receptor and tumor cell adhesion by lipoxygenase products of arachidonic acid and linoleic acid. | 1989 | Cancer Res. | pmid:2492204 |